Crossmark

Costs and consequences of cardiovascular toxicity due to Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia

Crossref DOI link: https://doi.org/10.1016/j.repc.2025.11.007

Published Print: 2026-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Figueira, Débora

Costa, João

Fiuza, Manuela

Magalhães, Andreia

Paiva, Mariana

Saraiva, Mariana

Gonçalves-Teixeira, Pedro

Borges, Margarida
Funding

Funding for this research was provided by:

AstraZeneca
License Information

Text and Data Mining valid from 2026-03-01

Text and Data Mining valid from 2026-03-01

Version of Record valid from 2026-01-23
More Information

This article is maintained by: Elsevier

Article Title: Costs and consequences of cardiovascular toxicity due to Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia

Journal Title: Revista Portuguesa de Cardiologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repc.2025.11.007

Content Type: article

Copyright: © 2026 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.